Literature DB >> 11259103

Squamous cell carcinoma antigen suppresses radiation-induced cell death.

A Murakami1, Y Suminami, H Hirakawa, S Nawata, F Numa, H Kato.   

Abstract

Previous study has demonstrated that squamous cell carcinoma antigen (SCCA) 1 attenuates apoptosis induced by TNF alpha, NK cell or anticancer drug. In this study, we have examined the effect of SCCA2, which is highly homologous to SCCA1, but has different target specificity, against radiation-induced apoptosis, together with that of SCCA1. We demonstrated that cell death induced by radiation treatment was remarkably suppressed not only in SCCA1 cDNA-transfected cells, but also in SCCA2 cDNA-transfected cells. In these transfectants, caspase 3 activity and the expression of activated caspase 9 after radiation treatment were suppressed. Furthermore, the expression level of phosphorylated p38 mitogen-activated protein kinase (p38 MAPK) was suppressed compared to that of the control cells. The expression level of upstream stimulator of p38 MAPK, phosphorylated MKK3/MKK6, was also suppressed in the radiation-treated cells. Thus, both SCCA1 and SCCA2 may contribute to survival of the squamous cells from radiation-induced apoptosis by regulating p38 MAPK pathway. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259103      PMCID: PMC2363809          DOI: 10.1054/bjoc.2000.1683

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  62 in total

1.  Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells.

Authors:  Y L Guo; K Baysal; B Kang; L J Yang; J R Williamson
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

2.  Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.

Authors:  T Maruo; K Shibata; A Kimura; M Hoshina; M Mochizuki
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

3.  Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.

Authors:  H Kato; T Nagaya; T Torigoe
Journal:  Gan       Date:  1984-05

4.  In vitro and in vivo induction of squamous cell carcinoma antigen (SCC) in a uterine cervical cancer cell line (SKG-IIIa) with peplomycin and sodium butyrate.

Authors:  S Nozawa; M Kojima; K Tukazaki; M Sakayori; R Iizuka; N Kagiyama
Journal:  Asia Oceania J Obstet Gynaecol       Date:  1990-06

5.  Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.

Authors:  N Mino; A Iio; K Hamamoto
Journal:  Cancer       Date:  1988-08-15       Impact factor: 6.860

6.  Individualization of the cutoff value for serum squamous-cell carcinoma antigen using a sensitive enzyme immunoassay.

Authors:  N Takeshima; K Nakamura; O Takeda; H Morioka; H Tamura; N Takasugi; H Kato
Journal:  Tumour Biol       Date:  1990

7.  Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma.

Authors:  P A Brioschi; P Bischof; C Delafosse; F Krauer
Journal:  Int J Cancer       Date:  1991-02-01       Impact factor: 7.396

8.  Squamous cell carcinoma antigen is a new member of the serine protease inhibitors.

Authors:  Y Suminami; F Kishi; K Sekiguchi; H Kato
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

9.  Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.

Authors:  H Kato; H Morioka; H Tsutsui; S Aramaki; T Torigoe
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

10.  Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2.

Authors:  D Belin; A Wohlwend; W D Schleuning; E K Kruithof; J D Vassalli
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  21 in total

Review 1.  SERPINB3 and B4: From biochemistry to biology.

Authors:  Yu Sun; Namratha Sheshadri; Wei-Xing Zong
Journal:  Semin Cell Dev Biol       Date:  2016-09-13       Impact factor: 7.727

2.  Radioresistance of Serpinb3a-/- Mice and Derived Hematopoietic and Marrow Stromal Cell Lines.

Authors:  Stephanie Thermozier; Xichen Zhang; Wen Hou; Renee Fisher; Michael W Epperly; Bing Liu; Ivet Bahar; Hong Wang; Joel S Greenberger
Journal:  Radiat Res       Date:  2019-07-11       Impact factor: 2.841

Review 3.  Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C.

Authors:  Andrea Martini; Andrea Gallotta; Patrizia Pontisso; Giorgio Fassina
Journal:  World J Hepatol       Date:  2015-12-18

4.  SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).

Authors:  Cristian Turato; Patrizia Pontisso
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2015

5.  Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells.

Authors:  Simi T Ahmed; James E Darnell
Journal:  Biochem Biophys Res Commun       Date:  2008-12-12       Impact factor: 3.575

6.  Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer.

Authors:  J Solassol; V Burcia; V Costes; J Lacombe; A Mange; E Barbotte; D de Verbizier; C Cartier; M Makeieff; L Crampette; N Boulle; T Maudelonde; B Guerrier; R Garrel
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

7.  SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling.

Authors:  Namratha Sheshadri; Joseph M Catanzaro; Alex J Bott; Yu Sun; Erica Ullman; Emily I Chen; Ji-An Pan; Song Wu; Howard C Crawford; Jianhua Zhang; Wei-Xing Zong
Journal:  Cancer Res       Date:  2014-09-11       Impact factor: 12.701

8.  Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death.

Authors:  Pieter J A de Koning; J Alain Kummer; Stefanie A H de Poot; Razi Quadir; Roel Broekhuizen; Anne F McGettrick; Wayne J Higgins; Bart Devreese; D Margaret Worrall; Niels Bovenschen
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

9.  SERPINB3 is associated with longer survival in transgenic mice.

Authors:  Gianmarco Villano; Mariagrazia Ruvoletto; Giulio Ceolotto; Santina Quarta; Fiorella Calabrese; Cristian Turato; Natascia Tono; Marika Crescenzi; Alessandra Biasiolo; Arianna Cattelan; Carlo Merkel; Angelo Avogaro; Angelo Gatta; Patrizia Pontisso
Journal:  Sci Rep       Date:  2013-10-28       Impact factor: 4.379

10.  Antiapoptotic serine protease inhibitors contribute to survival of allergenic TH2 cells.

Authors:  Mohamed H Shamji; Jeff N Temblay; Wei Cheng; Susan M Byrne; Ellen Macfarlane; Amy R Switzer; Natalia D C Francisco; Fedina Olexandra; Fabian Jacubczik; Stephen R Durham; Philip G Ashton-Rickardt
Journal:  J Allergy Clin Immunol       Date:  2017-10-26       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.